Deutsche Bank Ag\ Iovance Biotherapeutics, Inc. Transaction History
Deutsche Bank Ag\
- $245 Billion
- Q1 2025
A detailed history of Deutsche Bank Ag\ transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 685,146 shares of IOVA stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
685,146
Previous 867,576
21.03%
Holding current value
$1.16 Million
Previous $6.42 Million
64.47%
% of portfolio
0.0%
Previous 0.0%
Shares
37 transactions
Others Institutions Holding IOVA
# of Institutions
334Shares Held
247MCall Options Held
1.34MPut Options Held
1.61M-
Vanguard Group Inc Valley Forge, PA27.8MShares$46.9 Million0.0% of portfolio
-
Mhr Fund Management LLC New York, NY24.4MShares$41.3 Million12.15% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$35.9 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY12.7MShares$21.5 Million1.77% of portfolio
-
State Street Corp Boston, MA11MShares$18.7 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $267M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...